Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

Cancer History

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

Cancer Research

Overview of Cell Viability and Cytotoxicity

Secondary Brain Cancer

The Effects of Cancer on Family Life

Hot vs Cold: the differences between tumor types

The Cancer Cell Surface Proteome as a Therapeutic Target

Pediatric Cancer

Caring for a Loved One with Cancer

Metastatic Migration in Cancer may be Influenced by Metabolism

See more featured articles »

Hypoxia Markers and Their Importance

British Pioneers in Cancer Biology

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

Acidosis and Tumor Progression

Is Cancer a Metabolic Disorder?

Myc Mutations and Cancer

Cancer Management

What Role do Biobanks Play in Cancer Research?

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

What is the Tumor Microenvironment?

Cancer Glossary

Cancer Epidemiology

Living with Cancer Pain

The Biochemistry of Breast Cancer Screening

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

Targeted Cancer Therapies

Cancer Prevention: Lowering your Risk

Investigating the Molecular Mechanisms of Cancer

Cancer Prognosis

Exploiting Enzymes in Cancer Diagnosis and Therapy

Assay for Monitoring and Treating Malignant Brain Tumors

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

TARDIS: The Improved Method of Detecting Breast Cancer

Insight into Cancer Vaccines

What is Cancer of Unknown Primary?

Microfluidic cancer treatment screen combined with flow cytometry

Cancer Pain

What Causes Cancer?

Extracellular Vesicles as Floating Cancer Biomarkers

Cancer Classification

Cancer Screening Considerations: Balancing the Benefits and Risks

Cancer Pain Management

What is Cancer?

Transforming Cancer Care through Genomic Testing

Using Biomarkers to Detect Cancer

Effects of Social and Economic Deprivation on Cancer Mortality

Secondary Lung Cancer

CDK9 and Cancer

What is Merkel Cell Carcinoma?

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

Insights into Oncofertility

What is Tumorigenesis?

What is Immunochemotherapy?

Cancer Symptoms

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

Cutaneous Manifestations of Internal Malignancy

Why are Cancer Cell Lines Useful?

Cancer Diagnosis

Cancer Pathophysiology

Latest Cancer News and Research

Alligator Bioscience provides an update on mitazalimab

Alligator Bioscience, a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs, today provided a brief update regarding mitazalimab.

From Alligator Bioscience 11 Apr 2026

Non-clinical safety assessment crucial for CRISPR-based gene therapies

The rapid evolution of CRISPR/Cas genome editing has redefined the possibilities of cellular and gene therapy, enabling precise correction, disruption, and regulation of disease-associated genes.

10 Apr 2026

Nanomedicine offers targeted solutions for breast cancer treatment

Breast cancer (BCA) is one of the most common cancers worldwide, with high mortality and morbidity in women.

10 Apr 2026

Intense light therapy reduces hypoxia-induced heart damage in mice

Right ventricular (RV) remodeling and dysfunction are serious cardiovascular consequences due to prolonged hypoxic exposure, commonly seen in conditions such as chronic lung disease and high-altitude environments.

10 Apr 2026

Lung tumors shift identity making treatment more difficult

A new study co-led by the Institute for Systems Biology (ISB) shows that some lung cancers can change identity as they evolve, shifting from one cancer type to another in ways that may make them more aggressive and harder to treat.

10 Apr 2026

New collaboration targets muscle loss treatments for space missions

The Center for Myokine Convergence Research at Korea University College of Medicine (Director: Professor Hyeon Soo Kim, Department of Anatomy, Korea University College of Medicine) has signed a memorandum of understanding (MOU) with MFC to jointly develop therapeutics for muscle loss in astronauts.

10 Apr 2026

New PCR method enables full genome amplification of HPV16

Human papillomavirus (HPV) is a double-stranded circular DNA virus with a genome of approximately 7–8 kb. This study aimed to establish an overlapping extension polymerase chain reaction method for the amplification of the entire genome of HPV16.

10 Apr 2026

Talc not contaminated with asbestos shows no link to cancer

In a systematic review and meta-analysis, researchers found that occupational exposure to talc that is not contaminated with asbestos is not associated with an increase in the risk of lung cancer, mesothelioma, or laryngeal cancer.

10 Apr 2026

Sylvester Comprehensive Cancer Center opens new trial for neuroendocrine tumors

A clinical trial for patients with high-grade neuroendocrine tumors is now open for enrollment at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine.

10 Apr 2026

Large US study finds never-married adults face higher risk for most major cancers

A large US population-based study found that never-married adults had higher cancer incidence than ever-married adults across most cancer types, with the largest disparities seen in older adults and in Black men. The pattern was especially strong for HPV-related, tobacco-related, and several reproductive cancers, suggesting marital status may act as an important social marker of cancer risk.

9 Apr 2026

IBS diagnosis gaps persist across racial and gender groups in the U.S.

A national survey study led by UCLA Health and Cedars-Sinai Medical Center found significant disparities in how irritable bowel syndrome, or IBS, is diagnosed across sex and racial groups in the U.S., with men and Black patients considerably less likely than women and white patients to receive a formal diagnosis.

9 Apr 2026

Study maps DNA methylation changes driving MDS stem cell dysfunction

Published on April 01, 2026, in Volume 2, article number 19 of the journal Immunity & Inflammation, a collaborative team led by Prof. Cao at the Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, along with Dr. Liangding Hu at the Fifth Medical Center of Chinese PLA General Hospital, and Professors Qian Zhang and Yanmei Han at the National Key Laboratory of Immunity and Inflammation, Naval Medical University, has generated the first base-resolution DNA methylome of human MDS HSCs.

9 Apr 2026

Targeted diet helps reprogram aggressive neuroblastoma in mice

Researchers highlighted how an arginine- and proline-restricted diet combined with eflornithine reprogrammed MYCN-driven neuroblastoma in mice, pushing tumor cells out of the cell cycle and toward differentiation. The commentary argues that this metabolism-to-translation link could open a new path for testing targeted dietary strategies alongside cancer drugs in future clinical studies.

9 Apr 2026

New 3D organoid model advances pediatric glioma research and treatment

A three-dimensional experimental system has been developed to study the response to drugs in low-grade glioma, a tumor of the central nervous system that often occurs in children.

9 Apr 2026

CAR T therapy induces remission in multiple autoimmune diseases

For the first time, scientists have used a cutting-edge cell therapy called CAR-T to treat a patient with three different life-threatening autoimmune diseases that had resisted years of treatment.

9 Apr 2026

AI-powered chemistry accelerates discovery of selective cancer inhibitors

Recently, the Insilico team's research entitled "An Internal Sulfur-Lone Pair Interaction Enabled the Discovery of Potential and Sub-Family Selective PKMYT1 Inhibitors" was invited for publication as a cover Feature in ChemMedChem.

9 Apr 2026

Precision medicine tools offer hope for patients with rare blood cancers

Personalized approaches have dramatically improved outcomes for many patients with non-Hodgkin B-cell lymphomas—blood cancers that arise in immune cells called B cells—yet the same is not true for patients with more rare lymphoma types that originate in immune cells called T cells.

9 Apr 2026

OICR funds four Ontario teams to develop next-generation cancer therapies

Better cancer care depends on better treatment options. That's why the Ontario Institute for Cancer Research (OICR) is supporting four Ontario-based research teams working to develop the next generation of cancer therapies that are designed to be more effective at destroying tumors, have reduced side effects, and make cancer less likely to return.

9 Apr 2026

UVA scientists develop AI tools to accelerate new drug discovery

University of Virginia School of Medicine scientists have developed a bold new approach to drug development and discovery that could dramatically accelerate the creation of new medicines.

9 Apr 2026